Market closed
bluebird bio/$BLUE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About bluebird bio
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing, and commercializing potentially transformative gene therapies for severe genetic diseases.
Ticker
$BLUE
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
248
Website
bluebird bio Metrics
BasicAdvanced
$41M
-
-$24.84
0.82
-
Price and volume
Market cap
$41M
Beta
0.82
52-week high
$10.28
52-week low
$3.56
Average daily volume
425K
Financial strength
Current ratio
0.481
Quick ratio
0.246
Long term debt to equity
-537.062
Total debt to equity
-1,175.011
Interest coverage (TTM)
-11.86%
Management effectiveness
Return on assets (TTM)
-31.00%
Return on equity (TTM)
-295.35%
Valuation
Price to revenue (TTM)
0.479
Price to book
-1.28
Price to tangible book (TTM)
-0.86
Price to free cash flow (TTM)
-0.153
Growth
Revenue change (TTM)
184.12%
Earnings per share change (TTM)
-35.62%
3-year revenue growth (CAGR)
183.91%
3-year earnings per share growth (CAGR)
-52.90%
bluebird bio News
AllArticlesVideos
bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
Business Wire·6 days ago
Gene Therapy-Focused Bluebird Bio Receives Rival Takeover Offer, Stock Jumps
Benzinga·3 weeks ago
Bluebird bio receives non-binding bid for up to $110.5 million
Reuters·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for bluebird bio stock?
bluebird bio (BLUE) has a market cap of $41M as of April 22, 2025.
What is the P/E ratio for bluebird bio stock?
The price to earnings (P/E) ratio for bluebird bio (BLUE) stock is 0 as of April 22, 2025.
Does bluebird bio stock pay dividends?
No, bluebird bio (BLUE) stock does not pay dividends to its shareholders as of April 22, 2025.
When is the next bluebird bio dividend payment date?
bluebird bio (BLUE) stock does not pay dividends to its shareholders.
What is the beta indicator for bluebird bio?
bluebird bio (BLUE) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.